dabrafenib

Dabrafenib is a reversible ATP-competitive kinase inhibitor and targets the MAPK pathway. It is used alone or in combination with another medication to treat a type of skin cancer.. Reference standards of Dabrafenib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Dabrafenib Glucuronide
    [catalogue_number] => PA 31 0061019
    [category_ids] => ,79,80,71,78,70,82,89,88,95,
    [chemical_name] => 
    [weight] => 695.64
    [form] => C28H24F3N5O9S2
    [cas] => 2147682-66-2
    [pslug] => 2147682-66-2-dabrafenib-glucuronide-pa310061019
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 31 0061019

Dabrafenib Glucuronide


  • Catalogue No.:PA 31 0061019

  • CAS :

    2147682-66-2

  • Molecular Formula : C28H24F3N5O9S2

  • Molecular Weight : 695.64